Novavax (NVAX) Misses Q4 EPS by 1c, Beats on Revenues
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.05 --0%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Note: EPS may not be comparable
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $7.98 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- OceanaGold to acquire Ausgold in a deal valued at A$776M
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
